Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Rapid CommunicationAccelerated Communication

BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity.

Fiona Y. Carroll, Andreas Stolle, Philip M. Beart, Arnd Voerste, Isabelle Brabet, Frank Mauler, Cécile Joly, Horst Antonicek, Joël Bockaert, Thomas Müller, Jean Philippe Pin and Laurent Prézeau
Molecular Pharmacology May 2001, 59 (5) 965-973; DOI: https://doi.org/10.1124/mol.59.5.965
Fiona Y. Carroll
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Stolle
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip M. Beart
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnd Voerste
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Brabet
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Mauler
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cécile Joly
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Horst Antonicek
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joël Bockaert
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Müller
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Philippe Pin
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Prézeau
1 2 3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 59 no. 5 965-973
DOI 
https://doi.org/10.1124/mol.59.5.965
PubMed 
11306677

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received December 27, 2000
  • Accepted February 12, 2001
  • Published online May 1, 2001.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Fiona Y. Carroll1,
  2. Andreas Stolle2,
  3. Philip M. Beart3,
  4. Arnd Voerste2,
  5. Isabelle Brabet1,
  6. Frank Mauler2,
  7. Cécile Joly1,
  8. Horst Antonicek2,
  9. Joël Bockaert1,
  10. Thomas Müller2,
  11. Jean Philippe Pin1, and
  12. Laurent Prézeau1
  1. 1Institut National de la Santé et de la Recherche Médicale-Centre National de la Recherche Scientifique de Pharmacologie-Endocrinologie–UPR 9023, Montpellier, France (F.Y.C., I.B., C.J., J.B., J.P.P., L.P.); 2Bayer AG, PharmaResearch, Wuppertal, Germany (A.S., A.V., F.M., H.A., T.M.); and 3Department of Pharmacology, Monash University, Victoria, Australia (P.M.B.)
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: April 2001 to March 2021

AbstractFullPdf
Apr 20017653106
May 2001216084
Jun 2001123360
Jul 200151828
Aug 200162220
Sep 200141122
Oct 200131527
Nov 200111417
Dec 2001289
Jan 200251211
Feb 200221727
Mar 200252012
Apr 200231015
May 200211817
Jun 200211928
Jul 200232027
Aug 200231516
Sep 20021918
Oct 200242326
Nov 200241617
Dec 200241113
Jan 200311525
Feb 200311524
Mar 200312017
Apr 200321719
May 200353810
Jun 200312016
Jul 2003104712
Aug 2003112921
Sep 2003143712
Oct 2003145127
Nov 2003184616
Dec 2003133917
Jan 2004202912
Feb 2004112720
Mar 2004142014
Apr 20048159
May 2004133822
Jun 2004385512
Jul 200416459
Aug 200418349
Sep 2004124111
Oct 200420489
Nov 200417457
Dec 2004163010
Jan 200515338
Feb 2005143513
Mar 200514307
Apr 200552010
May 2005122410
Jun 2005143617
Jul 20055176
Aug 200510149
Sep 200582116
Oct 2005152313
Nov 2005102310
Dec 200573313
Jan 200693910
Feb 200614337
Mar 200652213
Apr 20068113
May 200642010
Jun 200671512
Jul 20062217
Aug 2006384
Sep 20065910
Oct 20066910
Nov 20064219
Dec 20065106
Jan 20074155
Feb 200791511
Mar 20076145
Apr 20076173
May 200773516
Jun 2007112018
Jul 20073139
Aug 20077105
Sep 20072134
Oct 200782110
Nov 200751710
Dec 200721312
Jan 200832120
Feb 200831410
Mar 200881411
Apr 20089158
May 200814614
Jun 20089127
Jul 20081245
Aug 20081355
Sep 2008211611
Oct 200816226
Nov 20081476
Dec 2008552
Jan 20099106
Feb 2009553
Mar 20091984
Apr 2009664
May 200910107
Jun 20091186
Jul 20095122
Aug 20091362
Sep 20091272
Oct 200912109
Nov 2009623
Dec 2009762
Jan 2010422
Feb 2010131313
Mar 201011138
Apr 20104166
May 20109178
Jun 20101684
Jul 20104109
Aug 201010158
Sep 20108189
Oct 201010198
Nov 2010192623
Dec 201071211
Jan 201113128
Feb 201118169
Mar 2011171121
Apr 2011101010
May 201111510
Jun 201191341
Jul 2011121161
Aug 20117557
Sep 2011251037
Oct 2011161411
Nov 2011111810
Dec 20117106
Jan 20121056
Feb 20121187
Mar 20121037
Apr 2012456
May 201218711
Jun 201211611
Jul 2012191313
Aug 2012868
Sep 2012131111
Oct 201215813
Nov 2012121116
Dec 2012321010
Jan 201317108
Feb 20131436
Mar 20131375
Apr 20138611
May 2013131113
Jun 20131163
Jul 2013764
Aug 2013832
Sep 20131624
Oct 20131491
Nov 2013831
Dec 2013533
Jan 20141232
Feb 20141377
Mar 2014748
Apr 201441013
May 2014945
Jun 20141267
Jul 2014974
Aug 2014301
Sep 2014475
Oct 20141453
Nov 20143118
Dec 20141543
Jan 20159203
Feb 20158176
Mar 20151053
Apr 20158102
May 20155139
Jun 201512125
Jul 201512135
Aug 20159204
Sep 20159127
Oct 2015770
Nov 2015884
Dec 2015496
Jan 201622267
Feb 20169123
Mar 2016191210
Apr 201613118
May 2016141617
Jun 201611104
Jul 201671510
Aug 20164114
Sep 20163112
Oct 20160156
Nov 20161158
Dec 20161298
Jan 201711612
Feb 201701816
Mar 201721813
Apr 2017185
May 20170186
Jun 20170132
Jul 20170218
Aug 20174224
Sep 20171202
Oct 20174256
Nov 20170316
Dec 20171156
Jan 20188145
Feb 201811814
Mar 20180297
Apr 201802411
May 201821511
Jun 20180186
Jul 20180195
Aug 2018096
Sep 20180127
Oct 201802111
Nov 201824912
Dec 20184658
Jan 20193630
Feb 20192914
Mar 20192413
Apr 20191610
May 20192732
Jun 20192445
Jul 20193731
Aug 20197742
Sep 20198654
Oct 20194221
Nov 20195361
Dec 20193031
Jan 20203840
Feb 20202621
Mar 20202062
Apr 2020702
May 2020300
Jun 2020310
Jul 2020600
Aug 2020210
Sep 20202012
Oct 2020811
Nov 20201320
Dec 20201261
Jan 20217161
Feb 202113150
Mar 2021931

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 59 (5)
Molecular Pharmacology
Vol. 59, Issue 5
1 May 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity.
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationAccelerated Communication

BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity.

Fiona Y. Carroll, Andreas Stolle, Philip M. Beart, Arnd Voerste, Isabelle Brabet, Frank Mauler, Cécile Joly, Horst Antonicek, Joël Bockaert, Thomas Müller, Jean Philippe Pin and Laurent Prézeau
Molecular Pharmacology May 1, 2001, 59 (5) 965-973; DOI: https://doi.org/10.1124/mol.59.5.965

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rapid CommunicationAccelerated Communication

BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity.

Fiona Y. Carroll, Andreas Stolle, Philip M. Beart, Arnd Voerste, Isabelle Brabet, Frank Mauler, Cécile Joly, Horst Antonicek, Joël Bockaert, Thomas Müller, Jean Philippe Pin and Laurent Prézeau
Molecular Pharmacology May 1, 2001, 59 (5) 965-973; DOI: https://doi.org/10.1124/mol.59.5.965
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAA Receptor Desensitization by Low GABA
  • Structure of the Diltiazem Receptor Site on Calcium Channels
  • 5-HT and Sleep
Show more Accelerated Communication

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics